Cedric Francois - Chief Executive Officer, Apellis Pharmaceuticals, Inc

As of February 14, 2022


Cedric Francois Net Worth

  • Net worth is estimated to be at least $52.38M
  • Owns at least 1,347,490 units of Apellis Pharmaceuticals, Inc stock
  • Sold an estimated value of $6.38M in the last 4 years at Apellis Pharmaceuticals, Inc

Cedric Francois Compensation at Apellis Pharmaceuticals, Inc in 2020

  • Earned a $618,769 salary and a $429 bonus
  • Rewarded $1,523,844 in stock value and options
  • Received a total compensation of $9,275,425

Cedric Francois Trading

  • Largest purchase of shares was 61,274 units , worth over $131.13K on March 18, 2020
  • Largest sale of shares was 35,638 units , worth over $1.5M on January 17, 2020
  • In total has made about 33 transactions over 4 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Cedric Francois Mailing Address

  • Mailing address is 6400 Westwind Way Suite A Crestwood KY 40014 KY

Apellis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492422/000119312521126688/d887358ddef14a.htm

Apellis Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 1,250 units sold on May 17, 2022 by Alec MacHiels worth over $48.98K
  • In the last 5 years, insiders at Apellis Pharmaceuticals, Inc sold an estimated value of $41.27M and bought an estimated value of $93.76M
  • The most active traders are Federico Grossi, CHIEF MEDICAL OFFICER,  Cedric Francois, Chief Executive Officer,  and Alec MacHiels, Director
  • Insider trading is most common in February, with the busiest year in 2021

Apellis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1